MAG expression promoters

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Reexamination Certificate

active

10969885

ABSTRACT:
A method for promoting myelination of an axon comprising administering 4-[α-hydroxy-5-(1-imidazolyl)-2-methylbenzyl]-3,5-dimethylbenzoic acid is disclosed.

REFERENCES:
patent: 2235621 (1997-05-01), None
patent: 195 41 146 (1997-04-01), None
patent: 0 881218 (1998-12-01), None
Mineo Tsuruta et al., “Tromboxane; Gosei Kouso Sogaizai (No. 1)”,Yakugaku Zasshi, vol. 109, No. 1, pp. 33-45 (1989).
Andrew P. Mizisin et al., “Myelin splitting, Schwann cell injury and demyelination in feline diabetic neuropathy”, Acta Neuropathol, 95, pp. 171-174, 1998.
G. Said et al., “Uncommon early-onset neuropathy in diabetic patients”, Journal of Neurology, vol. 245, No. 2, pp. 61-68, XP002299181, Feb. 1998.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

MAG expression promoters does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with MAG expression promoters, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and MAG expression promoters will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3754823

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.